Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Walk your way to recovery: new platform aims to get seniors moving after cancer surgery

NCT ID NCT06201884

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a walking platform every day after cancer surgery helps patients aged 65 and older regain their normal walking speed by the time they leave the hospital. Sixty participants will do short walking sessions starting the day after surgery. The goal is to see if this simple exercise can speed up recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
walking platform
What this could lead to
If it works, this could help elderly patients regain their walking ability faster after cancer surgery, reducing hospital stays and improving recovery.
What could go wrong
This is a small Phase 2 trial with only 60 participants, so results may not apply to everyone. The walking platform may not provide enough benefit over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women aged 65 or over * Candidate for scheduled major oncological surgery and/or surgery with high morbidity * Patient able to walk for 10 minutes on the walking platform at the time of the test * Patient affiliated to a social security system * Signature of informed consent prior to any specific study-related procedure Exclusion Criteria: * Patient with severe undernutrition (BMI\<18, and/or weight loss \>15% in 6 months or \>10% in 1 month) * Emergency surgery * Physical contraindications preventing use of the platform * Simultaneous participation in another clinical study that could compromise the conduct of this study * Patients deprived of their liberty, under guardianship or subject to a legal protection measure, or unable to express their consent. * Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elderly patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU CAEN

    RECRUITING

    Caen, France

  • Centre Francois Baclesse

    RECRUITING

    Caen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.